After markets closed Wednesday, Agenus Inc. (Nasdaq: AGEN) announced that it has acquired privately-held PhosImmune Inc., a company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE